ENTITY

Aadi Bioscience (AADI US)

11
Analysis
Health Care • United States
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers. Aadi Bioscience serves patients in the United States.
more
•11 Dec 2025 01:06•Broker

BRIDS Market Pulse: Chart of the Week – ICBP P/E Band – Core Profit

JCI rose 1.5% w-w, outperforming majority of EM peers (except for Korea’s Kospi index +4.4% w-w), bringing YTD performance to 21.9%.

Share
•28 Nov 2025 03:38•Broker

Coal: Demand Outlook Remains Soft, Though Seasonal Price Strength Still in Play (NEUTRAL)

Weak demand is partly balanced by constrained Indonesia’s production; government’s plan to cap 2026 production should be viewed positively.

Logo
175 Views
Share
•12 Nov 2025 06:04•Broker

Macro Strategy: Growth Over Differentials

Indonesia’s economy maintained solid momentum in 3Q25, recording 5.04% y-y (1.43% q-q) growth, although slightly easing from 2Q25’s 5.12%.

Logo
158 Views
Share
•03 Nov 2025 20:02•Broker

BRIDS Market Pulse : Chart of the Week – JCI Market Capitalization

MSCI has outlined two scenarios under this proposed method, which may effectively result in lower weighting for Indonesian stocks in MSCI EM Index.

Logo
204 Views
Share
bearish•Macroeconomics
•08 Sep 2025 20:11•Broker

BRIDS Market Pulse: Chart of the week – Metal sector vs. gold price

Foreign investors have continued to de-risk on largecap banks, namely BBCA (-US$195mn w-w, YTD: US$1.4bn) and BMRI (- US$45mn w-w, YTD: US$814mn).

Logo
254 Views
Share
x